Scientific efforts aiming at dissecting the cancer biology of TNBC have revealed several promising therapeutic targets including epidermal growth factor receptor (EGFR), a critical membrane-bound receptor tyrosine kinase for cancer progression. This evidence concerns the gene NTRK1 and cancer.